Name | Number of supported studies | Average coverage | |
---|---|---|---|
ciliated cell | 13 studies | 35% ± 8% | |
adipocyte | 7 studies | 31% ± 9% | |
hepatocyte | 5 studies | 60% ± 27% | |
cardiac muscle cell | 4 studies | 22% ± 4% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
liver | 3 studies | 30% ± 12% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
liver | 100% | 25936.40 | 226 / 226 | 95% | 127.33 | 386 / 406 |
pancreas | 100% | 4200.34 | 328 / 328 | 78% | 35.91 | 138 / 178 |
kidney | 64% | 632.51 | 57 / 89 | 59% | 13.15 | 532 / 901 |
adipose | 99% | 1939.46 | 1193 / 1204 | 0% | 0 | 0 / 0 |
breast | 78% | 1002.23 | 357 / 459 | 20% | 1.28 | 229 / 1118 |
heart | 96% | 5518.80 | 824 / 861 | 0% | 0 | 0 / 0 |
ovary | 84% | 1071.26 | 151 / 180 | 7% | 0.42 | 30 / 430 |
thymus | 77% | 416.26 | 501 / 653 | 1% | 0.04 | 8 / 605 |
lung | 44% | 383.73 | 253 / 578 | 18% | 1.38 | 207 / 1155 |
esophagus | 49% | 266.10 | 704 / 1445 | 5% | 0.29 | 10 / 183 |
blood vessel | 54% | 479.10 | 721 / 1335 | 0% | 0 | 0 / 0 |
stomach | 43% | 189.04 | 153 / 359 | 11% | 2.09 | 32 / 286 |
adrenal gland | 36% | 138.24 | 92 / 258 | 7% | 0.61 | 15 / 230 |
bladder | 38% | 115.10 | 8 / 21 | 4% | 0.16 | 19 / 504 |
intestine | 27% | 117.47 | 261 / 966 | 9% | 2.29 | 47 / 527 |
prostate | 31% | 122.78 | 76 / 245 | 4% | 0.29 | 19 / 502 |
uterus | 18% | 177.41 | 31 / 170 | 5% | 0.45 | 21 / 459 |
skin | 12% | 50.05 | 221 / 1809 | 3% | 0.10 | 15 / 472 |
muscle | 8% | 32.20 | 62 / 803 | 0% | 0 | 0 / 0 |
brain | 1% | 5.54 | 36 / 2642 | 3% | 0.31 | 21 / 705 |
peripheral blood | 1% | 7.32 | 11 / 929 | 0% | 0 | 0 / 0 |
spleen | 0% | 58.58 | 1 / 241 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 45 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0031640 | Biological process | killing of cells of another organism |
GO_0050778 | Biological process | positive regulation of immune response |
GO_0006958 | Biological process | complement activation, classical pathway |
GO_0006956 | Biological process | complement activation |
GO_0001701 | Biological process | in utero embryonic development |
GO_0045087 | Biological process | innate immune response |
GO_0005615 | Cellular component | extracellular space |
GO_0070062 | Cellular component | extracellular exosome |
GO_0005579 | Cellular component | membrane attack complex |
GO_0005576 | Cellular component | extracellular region |
GO_0005886 | Cellular component | plasma membrane |
GO_0005515 | Molecular function | protein binding |
Gene name | C6 |
Protein name | Complement component C6 Complement C6 |
Synonyms | |
Description | FUNCTION: Constituent of the membrane attack complex (MAC) that plays a key role in the innate and adaptive immune response by forming pores in the plasma membrane of target cells. |
Accessions | ENST00000433294.2 ENST00000337836.10 C9JC72 P13671 ENST00000263413.7 ENST00000417809.1 C9JX36 |